Borghaei H, Smith M, Millenson M, Thibodeau L, Kamiensky N, Schilder RJ
Phase I trial of combination therapy with Y-90 ibritumomab tiuxetan (Zevalin) and gemicitabine in patients with non-hodgkin's lymphoma
Blood. 2007 Nov;110(11):192B-193B.
Abstract